Prices delayed by at least 15 minutes | Print
Roquefort Therapeutics PLC (ROQ)
ORD 1PThis share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Company profile
Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses that are at an early stage in the medical sector including Drug and vaccine development; Diagnostics; Immuno-therapy; and Cell and gene therapies. The principal activity of the Company is to develop pre-clinical next generation medicines focused on hard to treat cancers.
Address
Eccleston Yards, 25 Eccleston Place
London
GBR
SW1W 9NF
Telephone
+44 2032909339
Forecast key dates
| Name | Key Date |
|---|---|
| Roquefort Therapeutics PLC Fourth Quarter Earnings Results for 2024 | 2025-04-25T00:00:00 |
| Roquefort Therapeutics PLC Annual Report for 2024 | 2025-04-25T00:00:00 |
| Roquefort Therapeutics PLC Second Quarter Earnings Results for 2024 | 2024-09-27T00:00:00 |
| Roquefort Therapeutics PLC Annual General Meeting for 2023 | 2024-06-28T09:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Roquefort Therapeutics PLC Fourth Quarter Earnings Results for 2023 | 2024-04-26T00:00:00 |
| Roquefort Therapeutics PLC Annual Report for 2023 | 2024-04-26T00:00:00 |
| Roquefort Therapeutics PLC Second Quarter Earnings Results for 2023 | 2023-09-27T00:00:00 |
| Roquefort Therapeutics PLC Annual General Meeting for 2022 | 2023-06-29T09:00:00 |
| Roquefort Therapeutics PLC Fourth Quarter Earnings Results for 2022 | 2023-06-05T00:00:00 |
| Roquefort Therapeutics PLC Annual Report for 2022 | 2023-06-05T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.